QSC RESEARCH GRADE
≥99% HPLC PurityMS ConfirmedJanoshik COAPharmaceutical-Grade5-Region Domestic Shipping
What is LC553 Super Shred?
LC553 Super Shred (High-potency injectable fat metabolism blend) combines: L-Carnitine 400mg/mL (high-concentration mitochondrial fatty acid transporter), MIC Blend 100mg/mL (Methionine + Inositol + Choline hepatic lipotropes), ATP 50mg/mL (direct cellular energy substrate), Albuterol 2mg/mL (selective β₂-adrenergic agonist — thermogenic and lipolytic), B12/Methylcobalamin 1mg/mL (energy metabolism coenzyme). The Albuterol component provides β₂-receptor-mediated thermogenesis and lipolysis on top of the lipotropic and carnitine activity — creating a comprehensive multi-mechanism fat metabolism research compound.
Research Applications
β₂-Adrenergic Lipolysis Research
Albuterol — selective β₂ agonist — cAMP-mediated lipolysis and thermogenesis in adipose tissue
High-Dose Carnitine Fatty Acid Oxidation
400mg/mL L-Carnitine maximises mitochondrial fatty acid transport for β-oxidation
Multi-Mechanism Fat Metabolism
β₂ agonism + carnitine + MIC lipotropics + ATP — comprehensive fat metabolism research
β₂ Agonist Pharmacology
Albuterol receptor selectivity (β₂ > β₁) and cAMP signalling kinetics
Athletic Performance & Body Composition
Combined β₂ thermogenesis, lipolysis, and carnitine fat oxidation research model
Quick Specs
| Form | Injectable solution (super shred blend) |
| Key Components | L-Carnitine 400mg · MIC Blend 100mg · ATP 50mg · Albuterol 2mg · B12 1mg per mL |
| Purity | ≥99% by HPLC — every batch |
| COA | Janoshik-independent, publicly verifiable |
| Vehicle | Sterile aqueous solution |
| Storage | 2–8°C | Protect from light |
| Shelf Life | 24 months (unopened) |

